Archive for the ‘Bioscience’ Category

BioOne Online Journals – BioScience

This site uses cookies to improve performance. If your browser does not accept cookies, you cannot view this site.

There are many reasons why a cookie could not be set correctly. Below are the most common reasons:

This site uses cookies to improve performance by remembering that you are logged in when you go from page to page. To provide access without cookies would require the site to create a new session for every page you visit, which slows the system down to an unacceptable level.

This site stores nothing other than an automatically generated session ID in the cookie; no other information is captured.

In general, only the information that you provide, or the choices you make while visiting a web site, can be stored in a cookie. For example, the site cannot determine your email name unless you choose to type it. Allowing a website to create a cookie does not give that or any other site access to the rest of your computer, and only the site that created the cookie can read it.

Read more from the original source:
BioOne Online Journals - BioScience

Alligator Bioscience AB


Our new website is optimized for the most current web browsing technology. If you are using an older web browser, part of our website may not function properly as designed. Please consider upgrading your browser for an error free experience.

Drug Development Candidate ADC-1004 has been shown to reduce myocardial infarction in a porcine ischemia reperfusion injury model. As part of the d

Alternativa Aktiemarknaden har trots ptryckningar frn Alligator Bioscience beslutat att nnu inte upphra med noteringen p Alternativas han

Alligatorbuilds value by using its proprietary human scFv antibody library ALLIGATOR-GOLD and the FIND technology platform to develop innovative antibody-based immuno-oncology compounds for unmet medical needs within cancer. Alligator Bioscience is focusing on discovery and early development phases and is growing an attractive pipeline of drug development candidates in various stages of preclinical and clinical development. ALLIGATOR-GOLD is a fully human synthetic kappa scFv library with large diversity (10 billion unique clones). ALLIGATOR-GOLD has been validated by selection of functionally active antibodies with sub-nanomolar affinities against several targets. FIND (Fragment Induced Diversity) technology is a powerful in vitro based antibody and protein optimization technology that creates functional libraries from which optimal variants of potential drug development candidates can be selected. ALLIGATOR-GOLD and FIND are fully integrated to give Alligator Bioscience the competitive advantage to develop immuno-oncology compounds with higher probability of success.

About us

Board of Directors


Scientific Advisors


ADC-1013 is an antibody-based immunotherapy, inducing anti-tumor immune effects through the activation of CD40 on antigen-presenting cells. ADC-1013 is currently in clinical phase I: safety and tolerability is assessed in a clinical trial of late stage cancer patients at 5 clinical sites in Europe. ADC-1013 was out-licensed to Janssen Biotech in August 2015.

ADC-1015 is a bispecific immuno-oncology compound. The drug candidate is based on the concept that the properties of two complementary immune activatingentities, OX40 and CTLA-4,are united into one moleculeto induce superior immune activation. Manufacturing for clinical trials was initiated in January 2016. ADC-1015 is currently in pre-clinical development.

ADC-1016 is a bispecific tumor-localizing immunotherapy, composed of one tumor-targeting moiety and one immune activatingmoiety. Immune activation is dependent on binding to the tumor target which reduces the risk of systemic toxicity. ADC-1016 is in late research phase.

Excerpt from:
Alligator Bioscience AB

Seahorse Bioscience – Making Cell Metabolism Even Easier

On June 6th will redirect to - but you'll still be able to find all our great content. Look for us under the PRODUCTS and SOLUTIONS tabs, as well as throughout the rest of the Agilent website.

Seahorse XF Analyzers and Agilent Mass Spectrometers enable life science researchers to examine cellular metabolic pathways, and obtain unprecedented insight into cell function; and the impact of genes, proteins, metabolites and drug-induced changes.

Determine the baseline and stressed phenotype, as well as the metabolic potential. These parameters combine to reveal the energy phenotype of your Cell.

Rapidly assesses cellular energy production & metabolic phenotype

Easily detects both rapid metabolic switching and longer term reprogramming

No metabolism expertise required

Learn More

Seahorse XFe Extracellular Flux Analyzers are the industry standard for measuring cell metabolism, simultaneously measuring the major energy-producing pathways of the cell

Get Wave - our latest software for your desktop Seahorse XF data analysis.

Wave for Desktop enables faster and easier analysis of both Seahorse XF and XFe data

Read the original here:
Seahorse Bioscience - Making Cell Metabolism Even Easier

Enzyme Bioscience Private Limited

Enzyme Bioscience Pvt.Ltd is an innovative manufacturer and provider of QUALITY Enzymes Products and services to the Bio Pharmaceuticals, Food, Feed industries since 2012.when its founder started with an enzyme Producing company specialized in plant origin enzyme, in order to better serve customers. He set up GMP Compliance Enzymes formulations facility in Surat (India).

Company is well equipped with Professional laboratory run by Qualified Personal to ensure Quality Control from Raw materials to finished products.

Enzyme Bioscience Pvt. Ltd. is a professional manufacturer of Allied formulations for Bio Pharmaceutical,Food/Feed Industry which bring added value to our valuable customers. Enzyme Bioscience Pvt. Ltd. has been recognized as a reliable partner that helps to improve their products because of consistent high quality, competitive price and excellent services.

We are Manufacturing Enzyme Formulations in both liquid and powder forms. Among the many varied applications for these enzymes are:

Bio Pharma Industry: Serratiopeptidase IP, Trypsin Chymotrypsin Mix, Fungal Diastase IP, Papain IP/USP, Bromelain 2400 GDU, Pancreatin IP/BP/USP, Pepsin IP,Azithromycin,Ox bile Extract.

Food Industry: Malt Extract, Starch, Grain Processing, Meat Tenderize Enzymes.

Feed Enzymes: Phytase, Animal Health & Nutrition Products such as quality feed additives and premixes, which solutions for natural growth promoting concept as well as other specific solutions which address dietary requirements for swine, poultry, dairy and beef cattle as well as aquaculture.

Enzyme Bioscience Pvt. Ltd. are offering higher quality products ie.higher enzyme activity, stability, less enzyme dosage,easier processing, higher yield, that are greatly helpful to improve their finished products.

Read the original:
Enzyme Bioscience Private Limited

Fumagillin Supplier | CAS 23110-15-8 | Tocris Bioscience

Price and Availability For Fumagillin pricing & availability please select your country from the drop down menu: USA United Kingdom -------------------------- Algeria Argentina Armenia Australia Austria Azerbaijan Bangladesh Belarus Belgium Bolivia Bosnia Herzegovina Brazil Bulgaria Cameroon Canada Chile China Colombia Croatia Cyprus Czech Republic Denmark Ecuador Egypt Estonia Fiji Finland France Georgia Germany Gibraltar Greece Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Japan Jordan Kenya Korea Kuwait Latvia Lebanon Libya Lithuania Luxembourg Macedonia Malaysia Malta Mexico Moldova Monaco Mongolia Montenegro Morocco Nepal Netherlands New Zealand Nigeria Norway Oman Pakistan Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Republic of Benin Romania Russia Saudi Arabia Serbia Singapore Slovakia Slovenia South Africa Spain Sri Lanka Suriname Sweden Switzerland Syria Taiwan Thailand Tunisia Turkey Ukraine United Arab Emirates United Kingdom Uruguay USA Uzbekistan Venezuela Vietnam Zambia Zimbabwe Submit By clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy.

Chemical Name: (2E,4E,6E,8E)-Mono[(3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methyl-2-butenyl)oxiranyl]-1-oxaspiro[2.5]oct-6-yl] 2,4,6,8-decatetraenedioic acid ester

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis. All Tocris products are intended for laboratory research use only.

Jaronski (1972) Cytochemical evidence for RNA synthesis inhibition by fumagillin. J.Antibiot. 25 327. PMID: 4630977.

Ingber et al (1990) Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348 555. PMID: 1701033.

Lowther et al (1998) The anti-angiogenic agent fumagillin covalently modifies a conserved active-site histidine in the Escherichia coli methionine aminopeptidase. Proc.Natl.Acad.Sci.U.S.A. 95 12153. PMID: 9770455.

Rodriguez-Nieto et al (2001) A re-evaluation of fumagillin selectivity towards endothelial cells. Anticancer Res. 21 3457. PMID: 11848509.

If you know of a relevant citation for this product please let us know.

Keywords: Fumagillin, supplier, Methionine, aminopeptidase-2, inhibitors, Proteases, Proteinases, antiangiogenics, angiogenesis, antibiotics

See the rest here:
Fumagillin Supplier | CAS 23110-15-8 | Tocris Bioscience


BioScience Web Site's mission is to organize the world's biological science information and make it universally accessible and useful by utilizing the skyrocketing success of the World Wide Web. more Web Search Search engines designed to search for biological science information on the World Wide Web ... These web search engines, are cross-linked, offers search for bioscience-related journals, books, protocols, images and videos,softwares, jobs, events, definitions, and more. Quick Links : Search engines (Bioinformatics, Protocol, Literature, Definition, Discussion, Career & Multimedia) & Suggest a site to Include/Exclude Dictionary Searchable dictionary with cross-referenced definitions of thousands of biological science terms ... This lexicon aims to be a one-stop source of information about all biological science terms and includes abbreviations, acronyms, slang, hypothesis, conventions, standards, and other types of words and phrases in related areas. Quick Links : Terms (A, B, C, D, E, F, G, H, I, J, K, L, M, N, O, P, Q, R, S, T, U, V, W, X, Y & Z) & Suggest a term/definition to Add/Edit/Delete Encyclopedia Comprehensive encyclopedia with information on all the major branches of knowledge in biological science ... This compendium is divided into thousands of biology articles with one article on each subject covered. It includes many useful cross-references and pointers to related resources elsewhere on the Internet, as well as bibliographical reference to paper publications. Quick Links : Disciplines, Topics (A, B, C, D, E, F, G, H, I, J, K, L, M, N, O, P, Q, R, S, T, U, V, W, X, Y & Z), Subcategories, Portal, History & People (A, B, C, D, E, F, G, H, I, J, K, L, M, N, O, P, Q, R, S, T, U, V, W, X, Y & Z) Link Directory Web directory developed for the concerned public, educators, students, and science professionals involved in biological studies ... This online guide to the World Wide Web is a human edited, searchable catalogue of external links to a broad range of biological science websites and resources, and organized into subject-based categories and sub-categories. Quick Links : Suggest a link, Search, & Links (New, Popular, Best rated & Our picks) Methods Web resource with emphasis on rapidly developing techniques and methodologies in the experimental biological sciences ... This article management system aims to be an on-line biological science lab manual which contains laboratory methods and protocols categorized by niche categories. Quick Links : Submit a method/protocol, Search & Latest methods/protocols Softwares Collection of softwares developed for educators, students, and science professionals involved in biological studies ... This repository intended to be a one stop location for educational software tools that encourage deep conceptual learning and open-ended scientific inquiry, and online research tools that run through the internet browser. Quick Links : Software tools (Sequence Manipulation Suite, Sequence Extractor, & BioPHP - Minitools) & Suggest a software to Include/Exclude Events Web calendar for organizing social, commercial or administrative events in biological sciences ... This calendar server is configured as a schedule management system for biological science conferences, seminars, workshops, courses, meetings, symposiums and other events Quick Links : Submit an event, Search & Views (Daily, Weekly, Monthly & Yearly) Jobs Web application for employment opportunities in biological sciences ... This job board application allows employers to log in and post a new job and jobseekers to browse the jobs and email their resume directly to the employer for that job. Quick Links : Register, Login & Post a job Blog Hosting Weblog publishing tool for biological science professionals ... People from all parts of the biological science spectrum are welcome to freely blog here! Quick Links : Create a blog & Login Map Partial or full screen interactive map of the biological science locations ... This online dynamic map shows locations as markers and includes institutes, research centers, laboratories, societies, organizations, companies, universities, libraries, museums, wildlife parks, botanical gardens, zoos and aquariums, and other places relating to biological sciences. Quick Links : Themes (BlogMap theme - shows a map in the header & MapOnly theme - shows a full screen map) & Suggest a location Web Hosting Web hosting service for biological science professionals ... This is a powerful free PHP and MySQL hosting including a free sub domain: You get a free sub domain of .LifeScientist.Net domain name such as Yourdomain.LifeScientist.Net. Quick Links : Sign up & Create web pages Toolbar Community toolbar to get the information you want from this site ... This fastest and easiest way allows you to get our freshest content delivered directly to your browser, check out all of our favorite places on the web, search the web, our site, and other useful engines, and receive our most important news and announcements instantly. Quick Links : Download toolbar

The rest is here:

Chinese Bioscience Association | CBA: Biotech, Life …

Future of the Life Science Industry - Innovation and Opportunities

The 18th Annual Conference of Chinese Bioscience Association October 10, 2015, Crown Plaza, Foster City, CA

We have invited industry and academia leaders to speak in this conference. Confirmed speakers include (no particular order):

Registration (including banquet style lunch):

CBA members registration:

Annual Conference CBA member rate Link

Non-CBA members registration:

Please use the bottom PayNow to pay.

Video highlights from 2014 Annual Conference at YouTube Link

2015 CBA Annual Conference Tentative Agenda

Oct 10, 2015 at Crowne Plaza Hotel, Foster City, California

Dr. Radoje (Rade) Drmanac, BGI

Dr. Jacqueline Law, Genentech

Dr. Lennart Mucke, Gladstone Institute of Neurological Disease

Dr. Tim Hoey, OncoMed

Dr. Janet Xiao, MoFo

Dr. Hiromitsu Nakauchi, Stanford

Dr. Scott Liu, CEO of Henlius Biotech

Dr. Xi Zhao-Wilson, BioMarker Pharmaceuticals

Dr. Licen Xu, Thermo Fisher

Dr. Ruhong Jiang, Applied Stem Cell

Chinese Bioscience Association | CBA: Biotech, Life ...

Bioscience – Kansas Department of Commerce


The science of living things human, animal and plant has long been a field in which Kansas has strengths. The state has a strong foundation in some areas of the biosciences and is well situated to take advantage of emerging opportunities in others. From the nationally recognized drug discovery and development enterprise at University of Kansas and Kansas companies, to the states historical agricultural leadership, to the selection of Kansas as home to the National Bio and Agro-Defense Facility, Kansas is ripe for bioscience growth.

With over 16,000 people employed in the biosciences and industry leaders calling our state home, we are working with our partners statewide to offer comprehensive support for world-class research, commercialization, and business expansion in the bioscience industry. The Kansas Bioscience Authority, created by the Kansas Economic Growth Act of 2004, can provide financial resources and customized support services to help address strategic issues critical to the success of emerging Kansas bioscience enterprises. KansasBio, a not-for-profit organization serving as the voice of the biosciences in Kansas, enhances the business and research climate, and works with state leaders to attract and retain bioscience talent, companies and funding.

Kansas invests in companies and universities working in bioscience sectors where Kansas has established leadership and expertise and the resources needed to benefit from new opportunities. Those include the following areas:


The animal health sector involves the production, marketing and use of domestic animals in agriculture, entertainment and companionship. Kansas is part of the renowned Kansas City Animal Health Corridor, home to one-third of the worlds animal health industry. Kansas seeks to leverage these strengths by attracting new animal health companies and expanding existing ones, encouraging research collaborations that will lead to novel products, and build the foreign animal disease expertise that led to Kansas selection as the site of the National Bio and Agro-Defense Facility to protect our nations food supply.


This sector encompasses work to safeguard and improve health with new drugs, therapies and medical devices. Kansas robust human health sector, from basic research to drug and device innovation to outstanding clinical care, provides benefits to Kansans and others worldwide. Clinical research for human health is a major emphasis for our state as Kansas is part of a bi-state region that ranks in the top five nationally for its concentration of clinical research firms. Kansas looks to work with companies who can bring drugs and devices to market faster and less expensively than traditional methods, provide new ways to diagnose disease and attract a growing share of the federal governments research investment.

BIO ENERGY Work in this sector focuses on creating fuel and chemicals out of biological material, often plant matter such as corn or switchgrass. Bioenergy products are easier on the environment and can help wean our nation from oil dependency. In this sector, Kansas hopes to develop the supply chain of feedstocks for bioenergy production, and drive collaborations that will lead to new businesses and products.


Kansas is known for its strong agricultural sector. Agriculture and products derived from crops will continue to play a key role in the states economy, particularly in rural communities. These industries have a global reach, too Kansas agricultural roots prime the state for advances in plant biology to help feed and clothe the world. Our state seeks advance new technologies, support innovative research, create new jobs and further advance Kansas leadership in these sectors.

Our commitment to the biosciences is strong and continues to grow. Let us show you how your company will benefit.


Whether by highway, rail or air, Kansas offers excellent transportation and marketing advantages for your business. Because were central and because weve focused on building and maintaining an outstanding infrastructure, its easier and cheaper to ship to and from Kansas. Were home to numerous production facilities, warehouses and distribution centers that have found shipping raw materials and finished goods is more profitable when youre located in the nations heartland.

Kansas strategic location, at the convergence of I-35 and I-70, places it at the crossroads of America. Our central location and excellent transportation network with access to interstate rail, trucking and air corridors put businesses within next-day freight service of 70 percent of the U.S.Highways Kansas ranks sixth for quality and access to transportation in all modes for getting products to market and for transporting individuals. We also rank third nationally in total road mileage with approximately 140,000 total road and street miles and over 10,000 highway miles. Thanks to our states proximity to major markets, our transit times and shipping rates for common carriers can compete with any in the country. Kansas motor carrier regulations, covering truck and trailer size and weight, mirror many federal guidelines.

Rail Service Kansas ranks in the top 10 in the United States in railroad mileage with almost 4,800 miles of track, 2.23 percent of all U.S. railroad miles. Our four Class I and 13 Class III secondary rail carriers ensure freight service to virtually anywhere in Kansas, since the countless tons of grain grown here have for decades mandated a comprehensive rail system.

Over 900 incorporated and unincorporated cities stand along Kansas tracks. Many communities are served by more than one railroad, and businesses in several cities can take advantage of reciprocal switching agreements between railroads. The Kansas City area, a convenient first stop en route to all major marketing regions, ranks as the second leading rail center in the nation.

Air Service Kansas City International Airport (KCI) and the Wichita Mid-Continent Airport are the largest airports serving the state, providing businesses with immediate access to major markets nationwide. KCI serves as the primary commercial airport for a four-state area for both passenger and air cargo service. These two airports contain state-of-the-art cargo handling facilities, main-deck loaders capable of handling the worlds largest freighter aircraft and an extensive highway system just minutes away to provide businesses with quick access to goods and markets.Inland Waterways The Port of Catoosa, an inland seaport located near Tulsa, Okla., is approximately 50 miles from the Kansas border. It is a year-round, economical alternative to other means of travel and is especially advantageous to businesses manufacturing large goods.


Foreign trade zones (FTZs) in Kansas provide a duty-free and quota-free entry point for foreign goods into specific areas under customs supervision for an unlimited period of time. Kansas offers a variety of sites managed by grantees in Kansas City (Zone 17) and Wichita (Zone 161).

Kansas has taken advantage of the new Alternative Site Framework (ASF) foreign trade zone designation intended to provide greater flexibility and expedite access to the benefits of the Foreign Trade Zone program. As a result, a company in the designated region is not restricted to a site specific FTZ, as the entire county is eligible for FTZ benefits under the ASF designation. This streamlined approach offers a quicker turnaround time and lower cost, allowing grantees to locate zone designation where companies are located.

The Kansas City FTZ has a number of Magnet and Usage-Driven sites, including a five-acre site with 220,000 square feet of above-ground covered space; a second five-acre site with a 26,000 square-foot warehouse, a 50,000 square-foot warehouse, 21 acres in the Leavenworth Area Business Center and over 1,000 acres at two locations in Topeka: Forbes Field/Topeka Air Industrial Park and Phillip Billard Airport/Industrial Park. The new ASF procedures were adopted for a five-county area including Douglas, Johnson, Leavenworth, Miami, and Wyandotte that allow for a six-week approval process for certain types of designations with a significant reduction in the companys out of pocket expenses.

The Wichita FTZ has received approval to use the new ASF procedures for a central region that includes Butler, Harvey, McPherson, Reno, Saline, Sedgwick and Sumner counties. The new system makes it faster and less expensive for area businesses to establish their facilities as foreign trade zones, with an estimated turnaround time of 30 to 40 days. Existing Magnet sites include 120 acres and 800,000 square feet of covered warehouse and assembly space in Wichita.

Goods brought into a zone or sub-zone may be stored, manipulated or mixed with domestic or foreign materials used in manufacturing processes or exhibited for sale. Anything shipped out of a zone into the United States customs territory is then subject to duties. Goods reshipped to foreign nations are never subject to U.S. customs duties.


One of the positive factors in the expansion of the Kansas economy is the Kansas worker. A highly motivated and well-educated workforce is ready to assist your firm. Though much of the states 2.9 million population is concentrated in its metropolitan areas, firms locating in any region of the state will find a high-quality workforce ready to put its talents to work.

Kansas education system is one of the best in the nation and a powerful factor contributing to the success of many businesses. Our education system has resulted in an adept, well-skilled and highly trainable labor force. The high school graduation rate and percentage of the population with a bachelors degree are both well above the national average. Kansas ranks in the top third nationally for percent of adults with a college degree and average ACT score. Kansas higher education system includes six Board of Regents universities, 26 community and technical colleges statewide and one municipal college. Both the University of Kansas and Kansas State University have well-known specialties in medical, pharmaceutical, bioscience, animal and food science.

Kansas is also a right-to-work state. This has helped the labor costs in Kansas stay below the national average. The current union membership percentage in Kansas is 6.8 percent, well below the U.S. average. In addition, we have multiple workforce training programs and initiatives for companies new to Kansas or Kansas businesses needing to expand or restructure. Our training programs can offer direct financial assistance to train your workforce, and our workforce development professionals can assist in the recruitment of labor to staff your new business. .COMPETITIVE UTILITY RATES

Kansas possesses a built-in advantage over other states when it comes to meeting your energy needs. With one of the largest natural gas fields in the world, Kansas is among the nations leading producers of natural gas. Also, our statewide power costs are competitive with the national average.


In an ongoing effort to improve the states business climate, Kansas lawmakers continue to find ways to reduce the cost of living and doing business in this state. Living costs are relatively low in Kansas at 8.7 percent below the national average, making our state one of the most affordable in the nation. Kansas housing is affordable, too, with the median value of owner-occupied housing more than 16.7 percent below the national average. In addition, Kansas ranks 15th overall for business competitiveness based on ten key economic factors, including workforce, education and transportation.


Kansas Bioscience Authority Animal Health

See more here:
Bioscience - Kansas Department of Commerce

Dimerix Bioscience

Developing and Commercialising Drug Therapies

Dimerix Bioscience is a public unlisted clinical stage drug discovery and development company, and a wholly owned subsidiary of Sun Biomedical Limited (ASX:SBN Sun Biomedical Home Page). Based in Melbourne, Dimerixs lead clinical program is a Phase 2 study in Chronic Kidney Disease, DMX-200. This study has repurposing of existing molecules at its core, and upon successful results from this study, Dimerix intends to pursue the pathway of registration of a product for an orphan indication. The study has been initiated at the Austin Hospital under the supervision of Professor Power, and is currently recruiting patients.

The therapeutic rationale for DMX-200 was developed from Dimerixs core patented technology, known as Receptor Heteromer Investigation Technology (Receptor HIT) which can be used to elucidate receptor interactions. Applying this technology to receptors such as G-protein coupled receptors (GPCRs), Dimerix is able to identify differences in signaling behavior when receptors interact as heteromers, as expected in vivo, compared with the traditional analysis of single target receptors in isolation. In recent years Dimerix has been approached by several top 10 Pharmaceutical companies, and has assisted these with their drug discovery programs by applying the HIT technology and in house knowledge. These studies have assisted in validating Dimerixs in vitro approach as a rationale for pursuing in vivo therapeutic studies.

Read more here:
Dimerix Bioscience

Whitney Laboratory for Marine Bioscience – St. Augustine, FL

Dr. Moroz and several members of his laboratory were recently featured in a story by Gainesvilles Our Town Magazine. The article follows the groundbreaking work done by the Moroz lab while at sea in their floating laboratory, a facility equipped with the latest in invertebrate sampling and genetic sequencing technology. Click here to read the

Please join us as Dr. Kate Mansfield from the University of Central Florida presents Tracking the sea turtle lost years for the Evenings at the Whitney public lecture series on Thursday, August 20th at 7 PM. Dr. Mansfield is a pioneer in satellite telemetry studies on wild sea turtles and will share her teams work

Whitney Lab undergraduate interns have been hard at work this summer helping out with our Marine Biology Summer Camp. Flagler College undergraduate internsMadison Skidmore and Cypres Ferran have been doing such a great job that they have caught the attention of the St. Augustine Record! Click here to read the full article!

Alexis Lanza, a Ph.D. student in the Seaver lab recently completed a journalism internship with the Society for Integrative and Comparative Biology (SICB). Lanza was 1 of 4 students who were awarded a learning opportunity on how to communicate a scientific topic to the general public. Her article detailed work by Dr. Sewall on the

The Sea Turtle release of Mahi earlier this month was a huge event! Over 200+ people attended the release includingstaff and volunteers from the Whitney Lab.Mahi, a juvenile green sea turtle, was rehabilitated by The Georgia Sea Turtle Center. After more than two years of intensive rehabilitation and care, the GSTC with local partners released

You may be thinking, wow, that little worm has such a complex nervous system with so many different nerve cells Yes indeed! In a recent paper entitled Nervous system development in lecithotrophic larval and juvenile stages of the annelid Capitella teleta published in the open access online journal Frontiers in Zoology on July 11,

Read the original:
Whitney Laboratory for Marine Bioscience - St. Augustine, FL

Amarantus Bioscience Holdings Inc. (AMBS … – InvestorsHub

(AMBS) Amarantus BioScience Holdings, Inc. Amarantus is a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and protein misfolding-related apoptosis. The company has licensedEltoprazine, a Phase 2B ready Parkinsons Levadopa induced Dyskinesia. The company has an exclusive worldwide license to the Lymphocyte Proliferation test("LymPro Test") is adiagnostic blood test for Alzheimers disease and is being evaluated as a diagnostic blood test for Traumatic Brain injury and Chronic Traumatic Encephalopathy.(MANF) is a human growth factor that plays a key role in the prevention of apoptosis (cell death). It is being developed for the potential treatment of RP, Parkinson's disease, Wolfram syndrome, diabetes, Alzheimer's disease and traumatic brain injury. Amarantus is a Founding Member of the Coalition for Concussion Treatment(#C4CT), a movement initiated in collaboration with Brewer Sports International seeking to raise awareness of new treatments in development for concussions and nervous-system disorders. The Company also owns intellectual property rights for the diagnosis of Parkinson's Disease("NuroPro")and the discoveryof neurotrophic facotrs("PhenoGuard"). ESS, previously known as PermaDermisbeing developed to be theonly tissue-engineered skin prepared from autologous (patient's own) skin cells consisting of both epidermal and dermal layers. A small harvested section of the patient's own skin can be grown to graft an area one hundredtimes its size in as little asthirty days.

MSPrecise is a groundbreaking advancement for the diagnosis of multiple sclerosis and is anticipated to play a pivotal role given the current high rate of misdiagnosis MSPrecise is a lab-developed test, and the successful completion of the validation study paves the way for this clinically important test to be commercialized in 2015. For further information, please,or connect withthecompany inFacebook,Twitter,LinkedIn&Google+

Amarantus Announces Publication of a Clinical Study of MSPrecise(R) Diagnostic for Identification of Relapsing-Remitting Multiple Sclerosis (RRMS) in the Journal GENE JULY 29, 2015 Amarantus BioScience Initiation of coverage Building up therapeutics assets July 27, 2015 Amarantus Diagnostics Establishes Strategic Advisory Committee-Advisors Bring Over 30 Years of Expertise in Successfully Commercializing Molecular Diagnostics Companies July 27, 2015 SeeThruEquity Initiates Coverage on Amarantus BioScience Holdings, Inc. with a Price Target of $45.34 JULY 24, 2015 Amarantus Diagnostics Meets Primary and Secondary Endpoints in Blinded, Multi-Center LP-002 Clinical Study for LymPro(R) Blood Diagnostic for Alzheimer's Disease and Confirms LymPro's Fit-For-Purpose Use in Clinical Trials at the 2015 Alzheimer's Association International Conference(R) July 22, 2015 Amarantus Announces First Patient Dosed in Eltoprazine Phase 2b Study for Treatment of Parkinson's Disease Levodopa-Induced Dyskinesia JULY 20, 2015 Amarantus Closes Cutanogen Acquisition By Jason Napodano, CFA - Wednesday, July 15, 2015 Amarantus Completes Acquisition of ESS From Lonza for the Treatment of Severe Burns - Amarantus Now Has Full Ownership of Cutanogen Corporation, Which Has Exclusive Worldwide License to Orphan Drug Product Candidate Engineered Skin Substitute (ESS) - July 15, 2015 Amarantus to Commence Trading on the OTCQX Marketplace Under Existing Ticker Symbol AMBS-Company Progressing Toward a National Stock Exchange Listing. -July 13, 2015 Amarantus Announces Issuance of United States Patent No. 9,066,903 Covering Proprietary Methods of Administration of Eltoprazine for the Treatment of Parkinson's Disease - Patent Provides IP Protection for Lead Product Candidate Eltoprazine for the Treatment of Parkinson's Disease - June 30, 2015 Amarantus Sets Sights On NASDAQ Jason Napodano, CFA - May 29, 2015 Amarantus Enters Into CRO Agreement With Chiltern International to Commence Phase 2b Clinical Development of Eltoprazine in Parkinson's Disease Levodopa-Induced Dyskinesia- Company Completes Investigator Meetings in U.S. and E.U. in Preparation for Study Launch - Enrollment and Dosing for 60-Patient PD-LID Study on Track to Commence 2Q 2015 May 21, 2015 Amarantus Reports First Quarter 2015 Financial Results and Business Overview- Eltoprazine Phase 2b clinical program on track to commence in 2Q 2015 - May 20, 2015 Amarantus Announces Successful Delivery and Distribution of MANF in Preclinical Model to Brain Areas Involved in Parkinson's Disease-Demonstrated MANF Can be Precisely Delivered to Parkinson's-Associated Brain Areas. May 15, 2015 MANF Begins its March Towards the Clinic May 14th, 2015 Amarantus Enters Into cGMP Manufacturing Agreement With Catalent Biologics for Production of MANF for Human Clinical Studies May 14, 2015 Amarantus Receives Notice of Allowance for U.S. Patent Application Covering Proprietary Methods of Administration and Compositions in the Treatment of Parkinson's Disease - Patent Issuance Will Provide IP Protection for Lead Product Candidate Eltoprazine for Treatment of Parkinson's Disease Levodopa-Induced Dyskinesia (PD-LID) May 13, 2015 Amarantus Announces the Presentation of Data Showing MANF's Positive Effect on Retinal Function at Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting May 7, 2015 Amarantus Receives Notice of Allowance for U.S. Patent Application Covering Proprietary Compositions of Matter and Methods of Use for MANF May 5, 2015 Amarantus Granted European Union Orphan Drug Designation for MANF for the Treatment of Retinitis Pigmentosa April 29, 2015 More News

Company Information

Amarantus BioScience Holdings, Inc. 655 Montgomery Street Suite 900 San Francisco, CA 94111

c/o ICS Corporate Services SA 29 quai du Mont Blanc CH-1201 Geneva Switzerland

Read more:
Amarantus Bioscience Holdings Inc. (AMBS ... - InvestorsHub

Aryu-Deva BioScience Renewal Complex

Indications Fine lines and wrinkles associated with expression lines that occur of time as well as environmental factors such as sun damage and smoking. Hyperpigmentation and/or uneven skin tone. Loss of elasticity and firmness. Spider veins. Lack of proper hydration.

Ingredients Proprietary Aloe/Vitamin/Mineral Blend (AVM), Tamarind Extract, Gotu Kola, Essential Oil Blend*, Palmitoyl Hexapeptide (Argireline), Palmitoyl Pentapeptide (Matrixyl), Hyaluronic Acid, Pomegranate extract, Olive leaf Extract, ALA, DMAE, Allantoin, DevaBrightT **, Herbal infusion Blend:*** Soy extract, EGF (Epidermal Growth Factor), Vitamin E Oil, Vitamins A and B2, CoQ10; guar gum and gum Arabic; Certified kosher and vegan xanthan gum & potassium sorbate; essential oil of lemongrass. * Essential Oil Blend:(Sunflower, Hemp seed, Jojoba, Borage, Evening Primrose, Sesame, Sea Buckthorn, Almond & grapeseed) ** DevaBright: (proprietary herbal blend of Licorice root, Kojic acid & Uva ursi) *** Botanical Actives (herbal infusion): Bladderwrack, Eyebright, Slippery Elm, Fennel seed, Chickweed, Neem leaf, Skullcap, Echinacea, Calendula flowers, Bilberry (vitamin C bioflavanoids), Ginko leaf, Hawthorne berry, Green Tea, Marshmallow root, St. Johns Wort, Rosemary leaf & Alfalfa

Directions Twice a day, after cleansing skin, pat dry and apply small quantity evenly to face, neck and exposed'V' of chest. Concentrate on expression lines and areas most affected by sun damage and dryness, as well as areas of uneven pigment and loss of firmness.

Visit link:
Aryu-Deva BioScience Renewal Complex

Bioscience Technology | Daily news and top headlines for …

July 7, 2015 10:11 am | Fluid Metering, Inc. | Product Releases |

Miniature, stepper driven valveless OEM Pumps from Fluid Metering Inc. (FMI) are ideal for low and micro-volume fluid control in medical diagnostic and clinical chemistry instrumentation.

When scientists develop cancer therapies, they target the features that make the disease deadly: tumor growth, metastasis, recurrence and drug resistance. In epithelial cancers cancers of the breast, ovaries, prostate, skin and bladder, which begin in the organs lining these processes are controlled by a genetic program called epithelialmesenchymal transition.


Polar bears are at risk of dying off if humans don't reverse the trend of global warming, a blunt U.S. government report filed Thursday said.


Unveiling how the 20,000 or so proteins in the human body workand malfunctionis the key to understanding much of health and disease. Now, researchers developed a new technique that allows scientists to better understand an elusive step critical in protein formation.


A therapy that replaces the faulty gene responsible for cystic fibrosis in patients' lungs has produced encouraging results in a major UK trial.


More here:
Bioscience Technology | Daily news and top headlines for ...

VIVO: Summary for Meridian Bioscience Inc.- Yahoo! Finance

Quotes are real-time for NASDAQ, NYSE, and NYSE MKT. See also delay times for other exchanges. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.

Fundamental company data provided by Capital IQ. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). International historical chart data, daily updates, fund summary, fund performance, dividend data and Morningstar Index data provided by Morningstar, Inc. Orderbook quotes are provided by BATS Exchange. US Financials data provided by Edgar Online and all other Financials provided by Capital IQ. International historical chart data, daily updates, fundAnalyst estimates data provided by Thomson Financial Network. All data povided by Thomson Financial Network is based solely upon research information provided by third party analysts. Yahoo! has not reviewed, and in no way endorses the validity of such data. Yahoo! and ThomsonFN shall not be liable for any actions taken in reliance thereon.

See the rest here:
VIVO: Summary for Meridian Bioscience Inc.- Yahoo! Finance

Bioscience Horizons

View Current ContentBrowse the ArchiveBrowse by Subject Category Bioscience Horizons: the International Journal of Student Research

Bioscience Horizons is a free online journal publishing the best undergraduate and taught masters bioscience research from around the world. The journal provides a forum for students, their supervisors and universities, to showcase high quality student research work, strengthening the link between teaching and research in higher education. All papers are written by students and can come from a variety of research projects. Manuscripts are rigorously reviewed by academic experts before publication.

Manuscripts can be submitted at any time of the year on a continuous publication basis.

Frequently Asked Questions

Click here to find out more about the Bioscience Horizons Chair's Prize.

The ideal candidate would be a current PhD student or Postdoctoral researcher who is keen on science communication. We hope that the position will provide useful insight and experience, of value in their academic career. Click here to find out more!

Bioscience Horizons Highly Commended for Publishing Innovation

Bioscience Horizons has been awarded a Highly Commended certificate by the Association of Learned and Professional Society Publishers (ALPSP) for publishing innovation. Click here for more information.

How do I submit a manuscript to this Journal? Students (with their supervisor/academic sponsor's permission) can submit a manuscript directly for consideration by the Editorial Board. To submit a manuscript:

1. Speak to your supervisor/academic sponsor about the work you wish to submit and obtain their permission 2. Format your manuscript according to the Instructions for Authors 3. Register your manuscript via our submission portal here:

Read more here:

Bioscience Horizons